These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7640859)

  • 21. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of multiple keratoacanthomas with intralesional fluorouracil.
    Eubanks SW; Gentry RH; Patterson JW; May DL
    J Am Acad Dermatol; 1982 Jul; 7(1):126-9. PubMed ID: 7107992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration.
    Goebeler M; Lurz C; Kolve-Goebeler ME; Bröcker EB
    Arch Dermatol; 2001 Aug; 137(8):1104-5. PubMed ID: 11493112
    [No Abstract]   [Full Text] [Related]  

  • 28. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 29. Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? - Comment on "Intralesional Methotrexate for Keratoacanthomas: A Case Series".
    López Sanz P; Fernández-Parrado M; Escario Travesedo E
    Actas Dermosifiliogr; 2024 Mar; 115(3):328-329. PubMed ID: 37716500
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effective treatment of recurrent keratoacanthoma using methotrexate].
    Schoon-Blaauw GH; Berretty PJ; Ideler AH; Tan-Go I
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):410-3. PubMed ID: 8127383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional Methotrexate for Keratoacanthomas: A Case Series.
    Silvestre Torner N; Gruber Velasco F; Romero Jiménez B; Vargas Laguna E
    Actas Dermosifiliogr; 2023 Mar; 114(3):279-281. PubMed ID: 36273558
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil.
    Leonard AL; Hanke CW
    J Drugs Dermatol; 2006 May; 5(5):454-6. PubMed ID: 16703783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on "Intralesional methotrexate for keratoacanthomas: A retrospective cohort study".
    Salido-Vallejo R; Redondo P
    J Am Acad Dermatol; 2020 Sep; 83(3):e203. PubMed ID: 32387632
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of keratoacanthoma with intralesional fluorouracil.
    Goette DK; Odom RB
    J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional methotrexate in dermatology: Diverse indications and practical considerations.
    Searle T; Ali FR; Al-Niaimi F
    Dermatol Ther; 2021 Jan; 34(1):e14404. PubMed ID: 33044042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma].
    Somlai B; Holló P
    Hautarzt; 2000 Mar; 51(3):173-5. PubMed ID: 10789078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of keratoacanthomas with intralesional fluorouracil.
    Odom RB; Goette DK
    Arch Dermatol; 1978 Dec; 114(12):1779-83. PubMed ID: 736584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.